- New Covid-19 vaccines targeting the nose and mouth stopped the spread of the virus in hamsters, a new study in Science Advances found. “This study shows that mucosal vaccines are superior to injected vaccines in terms of limiting viral replication in the upper airways and preventing spread to the next individual,” Jacco Boon, one of the study’s authors said in a press release. The study highlights that the spread of SARS-CoV-2 and other respiratory viruses could be controlled by nasal vaccines.
- A new review on Long Covid in The Lancet found the burden of Long Covid to be high on individuals, health systems, and national economies. The review highlighted the importance of early treatment, care, and diagnosis.“There is little published research on people who have had Long Covid for two years or more, but their chances of full recovery appear low. At this stage, the condition typically relapses and remits with compromised quality of life,” the authors wrote. Read more in this thread by author Trish Greenhalgh.
- The Polybio Research Foundation* has donated $1 million to the University of California San Francisco. The LIINC study team, which primarily focuses on Long Covid, will use the funding to study the root drivers of myalgic encephalomyelitis (ME/CFS) from people who had the disease before 2019. The study will include full-body imaging for T cell activation throughout the brain and spinal cord on a subset of participants.
*Editor’s note: The PolyBio Research Foundation, like The Sick Times, has received support from the Balvi and Kanro funds. Our newsroom operates independently of financial supporters.
Leave a Reply